- Aleafia Health (TSX:ALEF) is ramping up cannabis production at its facilities, despite temporarily closing its clinics last month
- This month, the company began operations at its newly licensed Niagara Facility, which is preparing for 2020’s outdoor cultivation season
- The company’s Paris facility is also increasing cultivation, to meet increased demand during the COVID-19 pandemic
- While its clinics remain closed, Aleafia has implemented virtual consultation and home delivery services to let operations continue
- Before the market opens, Aleafia Health (ALEF) is trading at C$0.35, with a market cap of $95.2 million
Cannabis cultivator, Aleafia Health (TSX:ALEF) is ramping up production at its facilities, despite temporarily closing its clinics last month.
While the company had to suspend operations at its physical clinics, it assured the public that production would remain ongoing.
Earlier this month, Aleafia began operations at its newly licensed Niagara Facility. The site is currently ramping up for the 2020 outdoor cultivation season.
Once the product is harvested, it will be transferred to the company’s Port Perry Facility, which also remains fully operational.
Aleafia is also ramping up production at its Paris facility, to meet increased demand for cannabis during the COVID-19 pandemic.
Since closing the clinics, Aleafia has implemented new social distancing and sterilisation procedures at its cultivation facilities.
While its clinics remain closed, the company has begun transferring to a virtual clinic service. Since its commencement, the virtual service has performed over 3,300 patient consultations remotely.
In tandem, Aleafia is now delivering cannabis directly to its customers, to safely continue operations while the clinics are closed.
Aleafia Health’s CEO, Geoffrey Benic, believes that the company is ready for the challenges which COVID-19 presents.
“With investments made over the last two years in virtual clinic services, we have been able to quickly transition to completing 100 per cent of physician-led patient consultations remotely, following the temporary, voluntary closure of our physical clinic locations.
“Likewise, we have accelerated the launch of our last-mile home delivery, to ensure patient access to medicine delivered directly to their own homes,” he said.
Geoffrey continued, saying that the company remains focused on disciplined sustainable growth, even in the wake of the pandemic.
Before the market opens, Aleafia Health (ALEF) is trading at C$0.35, with a market cap of $95.2 million.
